Skip to main content

Breadcrumb

  1. Home

A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Randomized Trial to Assess Patient Quality of Life and Function After Alternative Surgeries for Pathologic Fractures of the Femur

FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants

A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Phase 1 Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Solid Tumors

Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Fludeoxyglucose F-18 PET/CT in Predicting Response to Chemotherapy in Patients With Stage IIIA Non-small Cell Lung Cancer That Can Be Removed by Surgery

Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma

Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Carbon Ion Radiation Therapy for Locally Advanced Pancreatic Cancer

Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer

Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC

Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 163
  • Page 164
  • Page 165
  • Page 166
  • Page 167
  • Page 168
  • Page 169
  • Page 170
  • Page 171
  • …
  • Next page Next
  • Last page Last
Subscribe to